| abstract |
Compounds of formula I and their pharmaceutically acceptable salts are described. These compounds are inhibitors of plasma kallikrein. Also provided are pharmaceutical compositions containing at least one compound of the invention, and methods comprising the use of compounds and compositions of a compound of the invention in the treatment and prevention of diseases and pathological conditions characterized by undesirable activity of plasma kallikrein |